• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Array BioPharma Inc

+ Add to Watchlist

ARRY:US

3.9500 USD 0.0300 0.77%

As of 20:10:00 ET on 11/26/2014.

Snapshot for Array BioPharma Inc (ARRY)

Open: 3.9300 Day's Range: 3.9100 - 3.9800 Volume: 833,489
Previous Close: 3.9200 52wk Range: 2.9800 - 6.0700 1-Yr Rtn: -24.33%

Stock Chart for ARRY

No chart data available.
  • ARRY:US 3.9450
  • 1D
  • 1M
  • 1Y
3.9200
Interactive ARRY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARRY

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.7600
Est. EPS (USD) (06/2015) -0.7290
Est. PEG Ratio -
Market Cap (M USD) 521.26
Shares Outstanding (M) 131.96
30 Day Average Volume 1,331,817
Price/Book (mrq) -
Price/Sale (ttm) 14.6896
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARRY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARRY

Array BioPharma Inc., a discovery research company, creates drug candidates. The Company provides drug discovery products and services to create, evaluate, and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies.

Ron SquarerChief Executive OfficerVictor SandorChief Medical Officer
R Michael CarruthersChief Financial OfficerNicholas A SaccomanoChief Scientific Officer
More Company Profile & Key Executives for ARRY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil